Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors.

Autor: Stedman H; University of Pennsylvania Health System, Institute for Human Gene Therapy, Philadelphia 19104, USA., Wilson JM, Finke R, Kleckner AL, Mendell J
Jazyk: angličtina
Zdroj: Human gene therapy [Hum Gene Ther] 2000 Mar 20; Vol. 11 (5), pp. 777-90.
DOI: 10.1089/10430340050015671
Databáze: MEDLINE